# Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)

> **NCT00664222** · PHASE4 · COMPLETED · sponsor: **Tottori University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Chronic Stable Heart Failure

## Interventions

- **DRUG:** spironolactone + furosemide

## Key facts

- **NCT ID:** NCT00664222
- **Lead sponsor:** Tottori University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664222, "Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00664222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*